Health TrialsbyHealthPanel

Pneumococcal Infectious Diseases

2

Review clinical trials related to Pneumococcal Infectious Diseases. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Lot-to-Lot Consistency Clinical Trial of PCV13

A Phase IIIb clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13)developed by Sinovac Life Science Co., Ltd will be conducted in children aged 2 to 5 years. The objective of the study is to evaluate the the Lot-to-Lot consistency, immunogenicity and safety of Sinovac PCV13. The trial is a randomized, double-blind phase IIIb clinical trial.

Participants needed: 1,125
Trial details
Phase: Phase 3Age: 2-5Biological sex: AllType: InterventionalSponsor: Sinovac Life Sciences Co., Ltd.Updated: Sep 22, 2026Locations: 1
Eligibility criteria

Healthy children aged 2 to 5 years with stable health status [+3]

Received any pneumococcal vaccine prior to enrollment [+14]

Read more
Status: Not yet recruiting

Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)

A Phase III clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13)developed by Sinovac Life Science Co., Ltd will be conducted in infants aged approximately 2 months (42 to 89 days). The objective of the study is to evaluate the immunogenicity and safety of Sinovac PCV13. The trial is a randomized, double-blind, active controlled phase III clinical trial.

Participants needed: 500
Trial details
Phase: Phase 3Age: 42-89Biological sex: AllType: InterventionalSponsor: Sinovac Life Sciences Co., Ltd.Updated: May 18, 2026Locations: 1
Eligibility criteria

Health infants aged approximately 2 months (42 to 89 days) [+3]

Previous vaccination of any licensed or investigational pneumococcal vaccine, or... [+17]

Read more